BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING
|
Back to Search Results |
|
Model Number 442022 |
Device Problem
Contamination (1120)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/04/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event is unknown.The date received by manufacturer has been used for this field.Medical device expiration date: unknown.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
|
Event Description
|
It was reported that bd bactec¿ plus anaerobic/f culture vials (plastic) were contaminated which led to false patient results.Additional blood culture testing was performed, and the results were negative.Three patients were treated with bactrim based on the false results, but there was no report of adverse impact.The following information was provided by the initial reporter: erroneous results and adverse effect: were erroneous results and event reported? we are concerned the results were erroneous.How many false positives/negatives did the customer receive? we have 3 patients with same organism (2 in (b)(6), 1 in (b)(6)) what confirmatory testing was performed that determined the results were erroneous? more blood cultures ordered and were negative.Were any erroneous results reported to the doctors? yes- it has not been confirmed the results were erroneous but we are considering all possibilities as this is very unusual.If yes, were any patients treated based on erroneous results? treatment was initiated as patients were critically ill-outside of the one culture of stenotrophomonas if yes, did the erroneous treatment have any adverse impact to the patient(s)? na.Has this organism been reported and any treatment was initiated based on this result? all patients were treated with bactrim and all 3 patient¿s were in the icu-different rooms, no additional cultures growing same.
|
|
Manufacturer Narrative
|
The following fields have been corrected: b5: describe event d1: medical device brand name: bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) d2a: common device name: system, blood culturing.D2b: medical device type: mdb.D4: catalog: 442021.Lot # 1314589.Exp date: 31-aug-2022.Udi (b)(4).G5: pma/510(k)# k123903.H.6 investigation summary: upon further evaluation it was noticed that complaint received was from a product already expired.Investigation cannot be conducted to the retention samples since the product is already expired.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.The batch history record was not reviewed as the lot is expired, nonetheless batch history records are always reviewed prior to product release.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.The specimen must be collected using sterile techniques to reduce the chance of contamination.Do not use culture vials past their expiration date.Complaint is unconfirmed.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.H3 other text : see h.10.
|
|
Event Description
|
It was reported that bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) were contaminated which led to false patient results.Additional blood culture testing was performed, and the results were negative.Three patients were treated with bactrim based on the false results, but there was no report of adverse impact.The following information was provided by the initial reporter: erroneous results and adverse effect: ¿ were erroneous results and event reported? we are concerned the results were erroneous.¿ how many false positives/negatives did the customer receive? we have 3 patients with same organism (2 in may, 1 in july).¿ what confirmatory testing was performed that determined the results were erroneous? more blood cultures ordered and were negative: ¿ were any erroneous results reported to the doctors? yes- it has not been confirmed the results were erroneous but we are considering all possibilities as this is very unusual.¿ if yes, were any patients treated based on erroneous results? treatment was initiated as patients were critically ill-outside of the one culture of stenotrophomonas ¿ if yes, did the erroneous treatment have any adverse impact to the patient(s)? na ¿ has this organism been reported and any treatment was initiated based on this result? all patients were treated with bactrim and all 3 patient¿s were in the icu-different rooms, no additional cultures growing same.
|
|
Search Alerts/Recalls
|
|
|